InsiderSignalSign in

← Insider buys

Steven H Collis has bought stock on 2 days since Feb 2026

Director at Elevance Health, Inc., and 3 other companies

SEC CIK 0001191508 · Filings on SEC.gov ↗

$1.1MBought

$254.2MSold

Mar 6Last buy

Steven H Collis's record

3 months after each buy, from the first price a copier could get.

2 buys have 3 months of prices so far. A record shows here at 3.

Companies

Every filing

98 filings since Aug 2016, newest first

Elevance Health, Inc.

Director

$870K+469.0%Mar 6

Bausch & Lomb Corp

Director

$267K+154.0%Feb 24

Cencora, Inc.

Executive Chair

$12.2M−13.0%Nov 26

Cencora, Inc.

Executive Chair

$5.2M−7.0%Nov 21

Cencora, Inc.

Executive Chair

$5.1M−7.0%Oct 23

Cencora, Inc.

Chair, President and CEO

$5.2M−7.0%Sep 18

Cencora, Inc.

Chair, President and CEO

$2.6M−4.0%Aug 21

Cencora, Inc.

Chair, President and CEO

$2.4M−4.0%Jul 17

Cencora, Inc.

Chair, President and CEO

$2.5M−4.0%Jun 20

Cencora, Inc.

Chair, President and CEO

$2.4M−4.0%May 22

Cencora, Inc.

Chair, President and CEO

$2.6M−4.0%Apr 17

Cencora, Inc.

Chair, President and CEO

$2.6M−4.0%Mar 21

Cencora, Inc.

Chair, President and CEO

$8.7M−13.0%Dec 15

Cencora, Inc.

Chair, President and CEO

$5.1M−7.0%Dec 13

Cencora, Inc.

Chair, President and CEO

$4.9M−7.0%Nov 15

Cencora, Inc.

Chair, President and CEO

$4.6M−9.0%Oct 11

Cencora, Inc.

Chair, President and CEO

$1.9M−4.0%Sep 13

Amerisourcebergen Corp

Chair, President and CEO

$2.0M−4.0%Aug 9

Amerisourcebergen Corp

Chair, President and CEO

$2.0M−4.0%Jul 12

Amerisourcebergen Corp

Chair, President and CEO

$1.9M−4.0%Jun 14

Amerisourcebergen Corp

Chair, President and CEO

$1.8M−4.0%May 10

Amerisourcebergen Corp

Chair, President and CEO

$1.8M−4.0%Apr 13

Amerisourcebergen Corp

Chair, President and CEO

$1.6M−4.0%Mar 15

Amerisourcebergen Corp

Chair, President and CEO

$1.7M−4.0%Feb 16

Amerisourcebergen Corp

Chair, President and CEO

$1.7M−4.0%Jan 19

Amerisourcebergen Corp

Chair, President and CEO

$13.1M−23.0%Dec 14

Amerisourcebergen Corp

Chair, President and CEO

$1.6M−5.0%Oct 12

Amerisourcebergen Corp

Chair, President and CEO

$1.6M−5.0%Sep 15

Amerisourcebergen Corp

Chair, President and CEO

$1.7M−5.0%Aug 11

Amerisourcebergen Corp

Chair, President and CEO

$1.6M−5.0%Jul 14

Amerisourcebergen Corp

Chair, President and CEO

$1.6M−5.0%Jun 16

Amerisourcebergen Corp

Chair, President and CEO

$1.8M−5.0%May 12

Amerisourcebergen Corp

Chair, President and CEO

$1.9M−5.0%Apr 13

Amerisourcebergen Corp

Chair, President and CEO

$1.7M−5.0%Mar 9

Amerisourcebergen Corp

Chair, President and CEO

$3.4M−11.0%Feb 9

Amerisourcebergen Corp

Chair, President and CEO

$3.3M−11.0%Jan 13

Amerisourcebergen Corp

Chair, President and CEO

$2.1M−8.0%Dec 16

Amerisourcebergen Corp

Chair, President and CEO

$3.0M−10.0%Dec 15

Amerisourcebergen Corp

Chair, President and CEO

$2.1M−7.0%Nov 29

Amerisourcebergen Corp

Chair, President and CEO

$1.5M−5.0%Nov 18

Amerisourcebergen Corp

Chair, President and CEO

$3.0M−11.0%Nov 12

Amerisourcebergen Corp

Chair, President and CEO

$2.9M−12.0%Oct 14

Amerisourcebergen Corp

Chair, President and CEO

$3.0M−12.0%Sep 22

Amerisourcebergen Corp

Chair, President and CEO

$1.5M−6.0%Aug 19

Amerisourcebergen Corp

Chair, President and CEO

$2.5M−10.0%Aug 12

Amerisourcebergen Corp

Chair, President and CEO

$1.5M−6.0%Jul 21

Amerisourcebergen Corp

Chair, President and CEO

$2.4M−10.0%Jul 14

Amerisourcebergen Corp

Chair, President and CEO

$1.5M−6.0%Jun 17

Amerisourcebergen Corp

Chair, President and CEO

$2.5M−10.0%Jun 10

Amerisourcebergen Corp

Chair, President and CEO

$1.5M−6.0%May 19

About Steven H Collis

Steven H. Collis (born 1961 or 1962, age ~64) is an accomplished healthcare executive serving as an independent Director at Elevance Health, Inc. (ELV) since August 1, 2025, with appointments to the Audit and Finance Committees and designation as an SEC “audit committee financial expert.”( He holds the position of Executive Chairman of Cencora, Inc. (formerly AmerisourceBergen, NYSE: COR), a role he assumed in October 2024 after serving as Chairman, President, and CEO from 2016 to September 2024, and President and CEO from 2011 to 2016.(

Collis joined AmerisourceBergen in 1994 as President of the Specialty Group, building it into a market-leading specialty pharmaceutical distribution platform.( Under his leadership, the company executed key acquisitions like World Courier (2012), MWI Veterinary Supply (2015), and Alliance Healthcare (2021), alongside a strategic partnership with Walgreens Boots Alliance (2013), driving global expansion and innovation.( He earned a Bachelor of Commerce (Honors) from the University of the Witwatersrand and serves on boards including the International Federation of Pharmaceutical Wholesalers and American Red Cross.( Collis is independent under NYSE/SEC standards with no disclosed related-party conflicts at Elevance Health.(

Written by Perplexity from public sources.

Filings come from SEC EDGAR. Not investment advice.